Extended daily access to cocaine results in distinct alterations in homer 1b/c and NMDA receptor subunit expression within the medial prefrontal cortex

Synapse

Volumn 63, Issue 7, 2009, Pages 598-609

  Ben Shahar, Osnat ^a   Obara, Ilona ^a,b   Ary, Alexis W ^a   Ma, Natalie ^a   Mangiardi, Mario A ^a   Medina, Robert L ^a   Szumlinski, Karen K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Group 1 mGluRs; Homers; Immunoblotting; Rat; Self administration

Indexed keywords

COCAINE; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 5; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PROTEIN HOMER 1B; PROTEIN HOMER 1C; RECEPTOR SUBUNIT; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; COCAINE DEPENDENCE; CONTROLLED STUDY; DISEASE MODEL; DOSE TIME EFFECT RELATION; DRUG SELF ADMINISTRATION; HUMAN; IMMUNOBLOTTING; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BINDING; VENTRAL TEGMENTUM;

ANIMALS; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM AGENTS; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; IMMUNOBLOTTING; MALE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SELF ADMINISTRATION; TIME FACTORS; VENTRAL TEGMENTAL AREA;

EID: 67449084393     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20640     Document Type: Article

References (88)

1. Ahmed SH, Cador M. 2006. Dissociation of psychomotor sensitization from compulsive cocaine consumption. Neuropsychopharmacology 31:563-571.
2. Ahmed SH, Koob GF. 1998. Transition from moderate to excessive drug intake: Change in hedonic set-point. Science 282:298-300.
3. Ahmed SH, Koob GF. 2004. Changes in response to a dopamine receptor antagonist in rats with escalating cocaine intake. Psychopharmacology 172:450-454.
4. Ary AW, Szumlinski KK. 2007. Regional differences in the effects of withdrawal from repeated cocaine upon Homer and glutamate receptor expression: A two-species comparison. Brain Res 1184:295-305.
5. Bechara A, Damasio H. 2002. Decision-making and addiction (part I): Impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 40:1675-1689.
6. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE. 2001. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39:376-389.
7. Bechara A, Dolan S, Hindes A. 2002. Decision-making and addiction (part II): Myopia for the future or hypersensitivity to reward? Neuropsychologia 40:1690-1705.
8. Ben-Shahar O, Ahmed SH, Koob GF, Ettenberg A. 2004. The transition from controlled to compulsive drug use is associated with a loss of sensitization. Brain Res 995:46-54.
9. Ben-Shahar O, Moscarello JM, Jacob B, Roarty MP, Ettenberg A. 2005. Prolonged daily exposure to IV cocaine results in tolerance to its stimulant effects. Pharmacol Biochem Behav 82:411-416.
10. Ben-Shahar O, Moscarello JM, Ettenberg A. 2006. One hour, but not six hours, of daily access to self-administered cocaine results in elevated levels of the dopamine transporter. Brain Res 1095:148-153.
11. Ben-Shahar O, Keeley P, Cook M, Brake W, Joyce M, Nyffeler M, Heston R, Ettenberg A. 2007. Changes in levels of D1. D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine. Brain Res 1131:220-228.
12. Ben-Shahar O, Posthumus EJ, Waldroup SA, Ettenberg A. 2008. Heightened drug-seeking motivation following extended daily access to self-administered cocaine. Prog Neuropsychopharmacol Biol Psychiatry 32:863-869.
13. Bhargava HN, Kumar S. 1999. Sensitization to the locomotor stimulant effect of cocaine modifies the binding of [3H]MK-801 to brain regions and spinal cord of the mouse. Gen Pharmacol 32:359-363.
14. Bornovalova MA, Lejuez CW, Daughters SB, Zachary Rosenthal M, Lynch TR. 2005. Impulsivity as a common process across borderline personality and substance use disorders. Clin Psychol Rev 25:790-812.
15. Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S, Corsi M, Orzi F, Conquet F. 2001. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 4:873-874.
16. Clark L, Cools R, Robbins TW. 2004. The neuropsychology of ventral prefrontal cortex: Decision-making and reversal learning. Brain Cogn 55:41-53.
17. Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC. 2004. Cognitive inflexibility after prefrontal serotonin depletion. Science 304:878-880.
18. Clarke HF, Walker SC, Crofts HS, Dalley JW, Robbins TW, Roberts AC. 2005. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci 25:532-538.
19. Coffey SF, Gudleski GD, Saladin ME, Brady KT. 2003. Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Exp Clin Psychopharmacol 11:18-25.
20. Dackis C, O'Brien C. 2003. Glutamatergic agents for cocaine dependence. Ann NY Acad Sci 1003:328-345.
21. Dackis C, O'Brien C. 2005. Neurobiology of addiction: Treatment and public policy ramifications. Nat Neurosci 8:1431-1436.
22. Damasio AR. 1996. The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 351:1413-1420.
23. Di Chiara G. 2002. Nucleus accumbens shell and core dopamine: Differential role in behavior and addiction. Behav Brain Res 137:75-114.
24. Dworkin SI, Mirkis S, Smith JE. 1995. Response-dependent versus response-independent presentation of cocaine: Differences in the lethal effects of the drug. Psychopharmacology 117:262-266.
25. Fein G, Di Sclafani V, Meyerhoff DJ. 2002. Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. Drug Alcohol Depend 68:87-93.
26. Ferrario CR, Gorny G, Crombag HS, Li Y, Kolb B, Robinson TE. 2005. Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use. Biol Psychiatry 58:751-759.
27. Fitzgerald L, Ortiz J, Hamedani A, Nestler E. 1996. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci 16:274-282.
28. Floresco SB, McLaughlin RJ, Haluk DM. 2008. Opposing roles for the nucleus accumbens core and shell in cue-induced reinstatement of food-seeking behavior. Neuroscience 154:877-884.
29. Franklin TR, Acton PD, Maldjian JA, Gray JD, Croft JR, Dackis CA, O'Brien CP, Childress AR. 2002. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry 51:134-142.
30. Gawin FH. 1991. Cocaine addiction: Psychology and neurophysiology. Science 251:1580-1586.
31. Gawin FH, Kleber HD. 1985. Cocaine use in a treatment population: Patterns and diagnostic distinctions. NIDA Res Monogr 61:182-192.
32. Gawin FH, Kleber HD. 1988. Evolving conceptualizations of cocaine dependence. Yale J Biol Med 61:123-136.
33. Grant S, Contoreggi C, London ED. 2000. Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia 38:1180-1187.
34. Hemby SE, Horman B, Tang W. 2005a. Differential regulation of ionotropic glutamate receptor subunits following cocaine self-administration. Brain Res 1064:75-82.
35. Hemby SE, Tang W, Muly EC, Kuhar MJ, Howell L, Mash DC. 2005b. Cocaine-induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non-human primates. J Neurochem 95:1785-1793.
36. Jentsch JD, Taylor JR. 1999. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology 146:373-390.
37. Kalivas PW, McFarland K. 2003. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology 168:44-56.
38. Kalivas PW, Volkow ND. 2005. The neural basis of addiction: A pathology of motivation and choice. Am J Psychiatry 162:1403-1413.
39. Kawashima R, Satoh K, Itoh H, Ono S, Furumoto S, Gotoh R, Koyama M, Yoshioka S, Takahashi T, Takahashi K, Yanagisawa T, Fukuda H. 1996. Functional anatomy of GO/NO-GO discrimination and response selection-a PET study in man. Brain Res 728:79-89.
40. Kelley AE, Schochet T, Landry CF. 2004. Risk taking and novelty seeking in adolescence: Introduction to part I. Acad Sci 1021:27-32.
41. Kennedy MB. 2000. Signal-processing machines at the postsynaptic density. Science 290:750-754.
42. Kenny PJ, Boutrel B, Gasparini F, Koob GF, Markou A. 2005. Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats. Psychopharmacology 179:247-254.
43. Kippin TE, Fuchs RA, See RE. 2006. Contributions of prolonged contingent and noncontingent cocaine exposure to enhanced reinstatement of cocaine seeking in rats. Psychopharmacology 187:60-67.
44. Konishi S, Nakajima K, Uchida I, Sekihara K, Miyashita Y. 1998. No-go dominant brain activity in human inferior prefrontal cortex revealed by functional magnetic resonance imaging. Eur J Neurosci 10:1209-1213.
45. Lim KO, Choi SJ, Pomara N, Wolkin A, Rotrosen JP. 2002. Reduced frontal white matter integrity in cocaine dependence: A controlled diffusion tensor imaging study. Biol Psychiatry 51:890-895.
46. Lim S, Naisbitt S, Yoon J, Hwang JI, Suh PG, Sheng M, Kim E. 1999. Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development. J Biol Chem 274:29510-29518.
47. Loftis JM, Janowsky A. 2000. Regulation of NMDA receptor subunits and nitric oxide synthase expression during cocaine withdrawal. J Neurochem 75:2040-2050.
48. Loftis JM, Janowsky A. 2003. The N-methyl-D-aspartate receptor subunit NR2B: Localization, functional properties, regulation, and clinical implications. Pharmacol Ther 97:55-85.
49. Mantsch JR, Yuferov V, Mathieu-Kia AM, Ho A, Kreek MJ. 2004. Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats. Psychopharmacology 175:26-36.
50. Mantsch JR, Cullinan WE, Tang LC, Baker DA, Katz ES, Hoks MA, Ziegler DR. 2007. Daily cocaine self-administration under long-access conditions augments restraint-induced increases in plasma corticosterone and impairs glucocorticoid receptor-mediated negative feedback in rats. Brain Res 1167:101-111.
51. Matochik JA, London ED, Eldreth DA, Cadet JL, Bolla KI. 2003. Frontal cortical tissue composition in abstinent cocaine abusers: A magnetic resonance imaging study. Neuroimage 19:1095-1102.
52. McFarland K, Kalivas PW. 2001. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21:8655-8663.
53. McFarland K, Lapish CC, Kalivas PW. 2003. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 23:3531-3537.
54. Monterosso J, Ehrman R, Napier KL, O'Brien CP, Childress AR. 2001. Three decision-making tasks in cocaine-dependent patients: Do they measure the same construct? Addiction 96:1825-1837.
55. O'Dell LE, Manzardo AM, Polis I, Stouffer DG, Parsons LH. 2006. Biphasic alterations in serotonin-1B (5-HT1B) receptor function during abstinence from extended cocaine self-administration. J Neurochem 99:1363-1376.
56. Paoletti P, Neyton J. 2007. NMDA receptor subunits: Function and pharmacology. Curr Opin Pharmacol 7:39-47.
57. Paterson NE, Markou A. 2003. Increased motivation for self-administered cocaine after escalated cocaine intake. Neuroreport 14:2229-2232.
58. Paterson NE, Markou A. 2005. The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats. Psychopharmacology 179:255-261.
59. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates, 4th ed. San Diego: Academic Press, An Imprint of Elsevier.
60. Pierce RC, Kalivas PW. 1997. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192-216.
61. Pierce RC, Meil WM, Kalivas PW. 1997. The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission. Psychopharmacology 133:188-195.
62. Pirot S, Glowinski J, Thierry AM. 1996. Mediodorsal thalamic evoked responses in the rat prefrontal cortex: Influence of the mesocortical DA system. Neuroreport 7:1437-1441.
63. Pulvirenti L, Maldonado-Lopez R, Koob GF. 1992. NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat. Brain Res 594:327-330.
64. Robinson TE, Kolb B. 2004. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47 Suppl 1:33-46.
65. Rolls ET, Hornak J, Wade D, McGrath J. 1994. Emotion-related learning in patients with social and emotional changes associated with frontal lobe damage. J Neurol Neurosurg Psychiatry 57:1518-1524.
66. Seiwell AP, Reveron ME, Duvauchelle CL. 2007. Increased accumbens Cdk5 expression in rats after short-access to self-administered cocaine, but not after long-access sessions. Neurosci Lett 417:100-105.
67. Sheng M, Kim MJ. 2002. Postsynaptic signaling and plasticity mechanisms. Science 298:776-780.
68. Steketee JD. 2005. Cortical mechanisms of cocaine sensitization. Crit Rev Neurobiol 17:69-86.
69. Swanson CJ, Baker DA, Carson D, Worley PF, Kalivas PW. 2001. Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: A potential role for Homer. J Neurosci 21:9043-9052.
70. Szumlinski KK, Dehoff MH, Kang SH, Frys KA, Lominac KD, Klugmann M, Rohrer J, Griffin W III, Toda S, Champtiaux NP, Berry T, Tu JC, Shealy SE, During MJ, Middaugh LD, Worley PF, Kalivas PW. 2004. Homer proteins regulate sensitivity to cocaine. Neuron 43:401-413.
71. Szumlinski KK, Lominac KD, Kieschen MJ, Oleson EB, Dehoff MH, Schwarz MK, Seeburg PH, Worley PF, Kalivas PW. 2005a. Behavioral and neurochemical phenotyping of Homer1 mutant mice: Possible relevance to schizophrenia. Genes Brain Behav 4:273-288.
72. Szumlinski KK, Lominac KD, Oleson EB, Walker JK, Mason A, Dehoff MH, Klugmann M, Cagle S, Welt K, During M, Worley PF, Middaugh LD, Kalivas PW. 2005b. Homer2 is necessary for EtOH-induced neuroplasticity. J Neurosci 25:7054-7061.
73. Szumlinski KK, Ary AW, Lominac KD, Klugmann M, Kippin TE. 2008. Accumbens Homer2 overexpression facilitates alcohol-induced neuroplasticity in C57BL/6J mice. Neuropsychopharmacology 33:1365-1378.
74. Tang W, Wesley M, Freeman WM, Liang B, Hemby SE. 2004. Alterations in ionotropic glutamate receptor subunits during binge cocaine self-administration and withdrawal in rats. J Neurochem 89:1021-1033.
75. Tang W-X, Fasulo WH, Mash DC, Hemby SE. 2003. Molecular profiling of midbrain dopamine regions in cocaine overdose victims. J Neurochem 85:911-924.
76. Tessari M, Pilla M, Andreoli M, Hutcheson DM, Heidbreder CA. 2004. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking. Eur J Pharmacol 499:121-133.
77. Tu JC, Xiao B, Naisbitt S, Yuan JP, Petralia RS, Brakeman P, Doan A, Aakalu VK, Lanahan AA, Sheng M, Worley PF. 1999. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 23:583-592.
78. Vanderschuren LJMJ, Kalivas PW. 2000. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: A critical review of preclinical studies. Psychopharmacology 151:99-120.
79. Volkow N, Li TK. 2005. The neuroscience of addiction. Nat Neurosci 8:1429-1430.
80. Volkow ND. 2004. Imaging the addicted brain: From molecules to behavior. J Nucl Med 45:13N-16N,19N-20N,22N passim.
81. Volkow ND, Hitzemann R, Wang GJ, Fowler JS, Wolf AP, Dewey SL, Handlesman L. 1992. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 11:184-190.
82. Volkow ND, Wang GJ, Hitzemann R, Fowler JS, Wolf AP, Pappas N, Biegon A, Dewey SL. 1993. Decreased cerebral response to inhibitory neurotransmission in alcoholics. Am J Psychiatry 150:417-422.
83. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Dewey SL, Pappas N. 1997. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386:830-833.
84. White FJ, Hu XT, Zhang XF, Wolf ME. 1995. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther 273:445-454.
85. Wolf ME. 1998. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54:679-720.
86. Zhang XF, Hu XT, White FJ, Wolf ME. 1997. Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J Pharmacol Exp Ther 281:699-706.
87. Zhang X, Lee TH, Davidson C, Lazarus C, Wetsel WC, Ellinwood EH. 2007. Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors. Neuropsychopharmacology 32:377-387.
88. Zhang XX, Shi WX. 1999. Dendritic glutamate-induced bursting in prefrontal pyramidal cells: Role of NMDA and non-NMDA receptors. Zhongguo Yao Li Xue Bao 20:1125-1131.